These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1989205)
1. The clinical and biochemical effect of calcium channel blockers in organ transplant recipients on cyclosporine. Dy GR; Raja RM; Mendez MM Transplant Proc; 1991 Feb; 23(1 Pt 2):1258-9. PubMed ID: 1989205 [No Abstract] [Full Text] [Related]
2. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression. Weir MR Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018 [TBL] [Abstract][Full Text] [Related]
3. Bone pain that responds to calcium channel blockers. A retrospective and prospective study of transplant recipients. Barbosa LM; Gauthier VJ; Davis CL Transplantation; 1995 Feb; 59(4):541-4. PubMed ID: 7878759 [TBL] [Abstract][Full Text] [Related]
4. Use of cyclosporine in cadaveric renal transplantation in China. Xie T; Xu QJ Transplant Proc; 1988 Jun; 20(3 Suppl 3):99-101. PubMed ID: 3291336 [No Abstract] [Full Text] [Related]
5. An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients. Salomon DR Transplant Proc; 1991 Aug; 23(4):2115-8. PubMed ID: 1871827 [No Abstract] [Full Text] [Related]
7. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis. Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835 [TBL] [Abstract][Full Text] [Related]
8. Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine. Ahmed K; Michael B; Burke JF Clin Nephrol; 1997 Nov; 48(5):307-10. PubMed ID: 9403215 [TBL] [Abstract][Full Text] [Related]
9. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients. Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172 [TBL] [Abstract][Full Text] [Related]
10. Renal function and blood pressure in heart transplant recipients treated with cyclosporine. Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515 [TBL] [Abstract][Full Text] [Related]
11. The effect of cyclosporine A on long-term renal function in pediatric liver transplant recipients. Andrews WA; Arant BS; Fyock B; Gray S; Schlatter MG; Conlin C Transplant Proc; 1991 Feb; 23(1 Pt 2):1452-3. PubMed ID: 1989261 [No Abstract] [Full Text] [Related]
12. Biochemical abnormalities in serum and urine from renal transplant recipients receiving cyclosporine. Jones MC; Whiting PH; Innes A; Propper DJ; Edward N; Catto GR Transplant Proc; 1989 Feb; 21(1 Pt 2):1487-9. PubMed ID: 2652478 [No Abstract] [Full Text] [Related]
13. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation. Moore CK; Bristow MR; Renlund DG; Rasmussen LG; O'Connell JB Transplant Proc; 1990 Jun; 22(3 Suppl 1):25-9. PubMed ID: 2349736 [No Abstract] [Full Text] [Related]
14. Interaction of calcium blockers and cyclosporine. Wagner K; Henkel M; Heinemeyer G; Neumayer HH Transplant Proc; 1988 Apr; 20(2 Suppl 2):561-8. PubMed ID: 3284103 [No Abstract] [Full Text] [Related]
15. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study. Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446 [No Abstract] [Full Text] [Related]
16. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients. Kerman RH; Van Buren CT; Lewis RM; Kahan BD Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254 [No Abstract] [Full Text] [Related]
17. The role of calcium-channel antagonists in solid organ transplantation. Huntress JD; Papadakos PJ New Horiz; 1996 Feb; 4(1):129-33. PubMed ID: 8689268 [TBL] [Abstract][Full Text] [Related]
18. Effect of calcium-channel blockers on renal function in renal-graft recipients treated with cyclosporine. Hauser AC; Derfler K; Stockenhuber F; Wamser P; Marosi L; Balcke P N Engl J Med; 1991 May; 324(21):1517. PubMed ID: 2023618 [No Abstract] [Full Text] [Related]
19. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Chapman JR; Marcen R; Arias M; Raine AE; Dunnill MS; Morris PJ Transplantation; 1987 Jun; 43(6):860-4. PubMed ID: 3296353 [TBL] [Abstract][Full Text] [Related]
20. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients. Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533 [No Abstract] [Full Text] [Related] [Next] [New Search]